Ameritox Supports New Recommendations for Long-Term Opioid Therapy

Ameritox, a company that provides pain medication monitoring, announced its support for the new recommendations for urine drug monitoring for long-term opioid therapy presented at the American Academy of Pain Medicine’s 28th Annual Meeting.

Advertisement

Sign up for our FREE Pain E-Weekly for more coverage like this sent to your inbox!

The recommendations were created by an expert panel to answer questions physicians might have about medication monitoring and to standardize the use of medication monitoring in the physician community.

More Articles on Pain Management:
Study: Patient Movement an Accurate Indicator of Pain
Millennium Laboratories to Sponsor Physician Education at American Academy of Pain Medicine Annual Meeting
KY Senate Panel May Vote on Bill to Regulate Pain Clinics and Electronically Monitor Prescriptions Next Week

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.